India to Morocco: Escitalopram Export Trade Route

The India to Morocco Escitalopram corridor is one of India's established pharmaceutical export routes, with 113 shipments documented worth a combined $80.4M USD. The route is dominated by MEDISPRAY LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's escitalopram manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $711.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with escitalopram's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 30.6%, placing it at rank #16 among India's top escitalopram export destinations globally.

On the import side, key buyers of Indian escitalopram in Morocco include CIPLA MAROC, M/S. SUN PHARMACEUTICALS MOROCCO LL , M S SUN PHARMACEUTICALS MOROCCO LL and 8 others. CIPLA MAROC is the single largest importer with 67 shipments valued at $77.0M USD.

India's escitalopram exports to Morocco are driven primarily by a handful of large-scale manufacturers. MEDISPRAY LABORATORIES PRIVATE LIMITED with 73 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Morocco benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDISPRAY LABORATORIES PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 99% of total trade value on this route. The average shipment value of $711.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as s-citap 10 tablets ( escitalopram oxalate 10 mg) (inv.qty.8716 pack 10x10s=871600 nos) and s-citap 10 tablets ( escitalopram oxalate 10 mg) (inv.qty.8675 pack 10x10s=867500 nos), suggesting that buyers in Morocco tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLA MAROC is the largest importer with 67 shipments worth $77.0M USD — representing 96% of all escitalopram imports from India on this route. A total of 11 buyers are active on this corridor.